| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.09 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |